No black box warning on record for Cidofovir

As of the latest FDA labeling reviewed, Cidofovir (CIDOFOVIR ANHYDROUS) does not carry a black box warning. Standard warnings and precautions still apply — see the full Cidofovir medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Nephrotoxicity Dose dependent nephrotoxicity is the major dose-limiting toxicity related to cidofovir injection administration. Cases of acute renal failure resulting in dialysis and/or contributing to death have occurred with as few as one or two doses of cidofovir injection. Renal function (serum creatinine and urine protein) must be monitored within 48 hours prior to each dose of cidof

No black box warning on record for Cidofovir

Other warnings & precautions

WARNINGS Nephrotoxicity Dose dependent nephrotoxicity is the major dose-limiting toxicity related to cidofovir injection administration. Cases of acute renal failure resulting in dialysis and/or contributing to death have occurred with as few as one or two doses of cidofovir injection. Renal function (serum creatinine and urine protein) must be monitored within 48 hours prior to each dose of cidof

Cidofovir Black Box Warning

No black box warning on record for Cidofovir

Other warnings & precautions

Cidofovir Black Box Warning

No black box warning on record for Cidofovir

Other warnings & precautions